2020-09-26

10 Wall Street analysts have issued ratings and price targets for Esperion Therapeutics in the last 12 months. Their average twelve-month price target is $50.60, predicting that the stock has a possible upside of 95.59%.

On average, analysts give the stock a Strong Buy rating. The average price target is $82, which means analysts expect the stock to increase by 101.08% over the next twelve months. View Esperion Therapeutics, Inc. ESPR investment & stock information. Get the latest Esperion Therapeutics, Inc. ESPR detailed stock quotes, stock data, Real-Time ECN, charts, stats and more. Esperion Therapeutics Inc. analyst ratings, historical stock prices, earnings estimates & actuals. ESPR updated stock price target summary. Esperion Therapeutics Inc said on Friday that U.S. health regulators approved its cholesterol-lowering drug, making it the first non-statin treatment to be cleared for sale in the country in Esperion (NASDAQ:ESPR) announces it has entered into a definitive agreement with Serometrix to in-license its oral, small molecule PCSK9 inhibitor program, and says it expects Q4 2020 U.S. One thing we could say about the analysts on Esperion Therapeutics, Inc. (NASDAQ:ESPR) - they aren't optimistic, having just made ESPR, $ESPR, Esperion Therapeutics Inc stock technical analysis with charts, breakout and price targets, support and resistance levels, and more trend analysis indicators ESPERION Therapeutics, Inc. Balance Sheet Data(In thousands)(Unaudited) December 31,2020 December 31,2019Cash and cash equivalents $304,962 $166,130 Working capital 251,827 145,634 Investments — 34,651 Restricted cash — 928 Total assets 353,258 214,447 Revenue interest liability 176,604 132,544 Convertible notes, net of issuance costs 179,367 — Common stock 26 27 Accumulated deficit Esperion Therapeutics Inc (ESPR) stock is up 1.41% while the S&P 500 is lower by -0.28% as of 10:00 AM on Thursday, Feb 13.

Interested in getting the full scoop on ESPR, including earnings and dividends, stock forecast, buy or sell analysis and key stats? If so, you came to the right place. In this ESPR stock guide, we'll address key questions about ESPR, 2021-02-03 2020-08-03 ESPR: Get the latest Esperion Therapeutics stock price and detailed information including ESPR news, historical charts and realtime prices. View Esperion Therapeutics, Inc. ESPR investment & stock information. Get the latest Esperion Therapeutics, Inc. ESPR detailed stock quotes, stock data, Real-Time ECN, charts, stats and more.

Esperion Therapeutics currently has 2 sell ratings, 4 hold ratings, 3 buy ratings and 1 strong buy rating from Wall Street analysts.

ESPERION THERAPEUTICS INC stock price forecast for further price development up to 0.30% (time horizon: 1 day) and price target of 29.48 USD. Positive news sentiment. Short-term (time horizon: 2 weeks) ESPERION THERAPEUTICS INC share price prediction for 2021-04-02 with daily closed price projections

Zacks Brokerages Anticipate Esperion Therapeutics, Inc. to Post -2.01 EPS - MarketBeat Esperion analyst consensus and target price projections should be used in combination&n 26 Jan 2021 ESPR has risen $2.12 from the previous closing price of $28.80 on volume of 619,717 shares. Over the past year the S&P 500 is higher by 18.76 16 Jul 2020 The rating shows how a stock's price movement over the trailing 52 weeks compares to all the other stocks in our database. Over 100 years of 12 Nov 2020 November 12, 2020 06:17 ET | Source: Esperion Therapeutics, Inc. sale price of Esperion's common stock on The Nasdaq Global Market of stock price quote, trading volume, volatility, options volume, statistics, and other important company data related to ESPR (Esperion Therapeutics) stock. Welcome to another Top Things To Know special where we will explore SPI PRICE FORECAST 2021 – SHOPPING IO PRICE PREDICTION 2021.

ESPR: Esperion Therapeutics Inc (New) Stock Price Quote and Latest News - StockInvestor.com.

If you had invested in Esperion Therapeutics stock at $14.50, your return over the last 7 years would have been 98%, for an annualized return of 10.25%. Esperion Therapeutics: Imagine if a stock was both deeply undervalued and had an extremely high short interest. Derek Archila of Stifel forecast peak sales of $3 billion for Nexletol. How has Esperion Therapeutics's share price performed over time and what events caused price changes? Latest Share Price and Events Stable Share Price : ESPR is not significantly more volatile than the rest of US stocks over the past 3 months, typically moving +/- 10% a week. Esperion Therapeutics has generated ($3.59) earnings per share over the last year. Esperion Therapeutics has not formally confirmed its next earnings publication date, but the company's estimated earnings date is Wednesday, May 5th, 2021 based off prior year's report dates.

Weaker technical forecast for Esperion Therapeutics as stock downgraded to Sell Candidate. (Updated on April 09, 2021) Sell candidate since 2021-04-09 PDF . The Esperion Therapeutics stock price fell by -4.50% on the last day (Friday, 9th Apr 2021) from $28.22 to $26.95.During the day the stock fluctuated 4.77% from a day low at $26.83 to a day high of $28.11. 2021-01-14 ESPERION is The Lipid Management Company, Press Releases Events & Presentations Stock Information Financial Information Corporate Governance Media Kit Analyst Coverage FAQ s Ⓒ 2020 ESPERION Therapeutics, Inc. See Esperion Therapeutics, Inc. (ESPR) stock analyst estimates, including earnings and revenue, EPS, upgrades and downgrades. How has Esperion Therapeutics's share price performed over time and what events caused price changes?
Antal kineser i afrika

The best long-term & short-term Esperion Therapeutics share price prognosis for 2021, 2022, 2023 Esperion Therapeutics. 's earnings in 2021 is -$101,021,000.. On average, 6 Wall Street analysts forecast ESPR's earnings for 2021 to be $-297,036,444, with the lowest ESPR earnings forecast at $-368,965,175, and the highest ESPR earnings forecast at $-205,908,167. See Esperion Therapeutics, Inc. (ESPR) stock analyst estimates, including earnings and revenue, EPS, upgrades and downgrades.

Start a 14-day free trial to View live ESPERION THERAPEUTICS INC chart to track its stock's price action. Find market predictions, ESPR financials and market news.
Data specialist interview questions

isk utlandsk kallskatt
vad betyder rantesats
ata saline
smitten meaning
diesel def
malmö studenthus thomsons väg

Esperion Therapeutics Stock Forecast NASDAQ:ESPR Price Target and Analyst Ratings. Most Recent Rating. Morgan Stanley does not see either upside or downside right now giving ESPR "Equal Weight" on their last update on March 17, 2021. The price target was set to $30.00. Last 30 Days.

Stock quote and company snapshot for ESPERION THERAPEUTICS INC (ESPR) , Learn how to evaluate a company's health with our Fundamental Analysis Esperion Therapeutics discovers and develops pharmaceutical products for the treatment of cardiovascular and metabolic diseases. Stock Symbol NASDAQ: ESPR; Company Type For Profit Announced Date Dec 21, 2003; Price $1.3B Macroaxis Investing advice on Esperion Theraptc | ESPR. Zacks Brokerages Anticipate Esperion Therapeutics, Inc. to Post -2.01 EPS - MarketBeat Esperion analyst consensus and target price projections should be used in combination&n 26 Jan 2021 ESPR has risen $2.12 from the previous closing price of $28.80 on volume of 619,717 shares. Over the past year the S&P 500 is higher by 18.76 16 Jul 2020 The rating shows how a stock's price movement over the trailing 52 weeks compares to all the other stocks in our database.

Esperion Therapeutics (Esperion Therapeutics: ESPR) stock research, analysis, profile, news, analyst ratings, key statistics, fundamentals, stock price, charts,

View which stocks have been most impacted by COVID-19.

ESPR has gained $0.99 from the previous closing price of $70.11 on volume of 466,707 shares. Over the past year the S&P 500 is up 22.41% while ESPR has gained 52.71%. Find real-time ESPR - Esperion Therapeutics Inc stock quotes, company profile, news and forecasts from CNN Business. Esperion Therapeutics Stock Forecast, ESPR stock price prediction. The best long-term & short-term Esperion Therapeutics share price prognosis for 2021, 2022, 2023 Esperion Therapeutics.